We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

25 hedge funds and large institutions have $1.33M invested in VistaGen Therapeutics in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

29% more capital invested

Capital invested by funds: $1.02M → $1.33M (+$301K)

14% more funds holding

Funds holding: 22 → 25 (+3)

0.01% more ownership

Funds ownership: 0.15% → 0.16% (+0.01%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$33.3K
2
DADC
D.A. Davidson & Co
Montana
+$24.6K
3
UBS Group
UBS Group
Switzerland
+$22.3K
4
SCM
Sitrin Capital Management
California
+$20.2K
5
RC
RBF Capital
California
+$11.4K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$19K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9K
3
BlackRock
BlackRock
New York
-$698
4
GI
Gradient Investments
Minnesota
-$27
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$615K -$19K -1,389 -3%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$132K – – –
Osaic Holdings
3
Osaic Holdings
Arizona
$90K – – –
DADC
4
D.A. Davidson & Co
Montana
$86K +$24.6K +1,800 +49%
HighTower Advisors
5
HighTower Advisors
Illinois
$70K – – –
Carson Wealth (CWM LLC)
6
Carson Wealth (CWM LLC)
Nebraska
$43K – – –
Northern Trust
7
Northern Trust
Illinois
$42K – – –
UBS Group
8
UBS Group
Switzerland
$41K +$22.3K +1,629 +171%
Jane Street
9
Jane Street
New York
$38K +$33.3K +2,432 New
Parallax Volatility Advisers
10
Parallax Volatility Advisers
California
$23K – – –
SCM
11
Sitrin Capital Management
California
$23K +$20.2K +1,478 New
LPL Financial
12
LPL Financial
California
$21K – – –
BlackRock
13
BlackRock
New York
$17K -$698 -51 -4%
RC
14
RBF Capital
California
$13K +$11.4K +833 New
FAIM
15
Financial Advocates Investment Management
Washington
$12K – – –
GBA
16
Garrison Bradford & Associates
New York
$11K – – –
Koshinski Asset Management
17
Koshinski Asset Management
Illinois
$11K – – –
HFM
18
Hartford Financial Management
Connecticut
$8K – – –
Morgan Stanley
19
Morgan Stanley
New York
$7K – – –
Commonwealth Equity Services
20
Commonwealth Equity Services
Massachusetts
$6K – – –
Renaissance Technologies
21
Renaissance Technologies
New York
$6K +$5.44K +398 New
TRCT
22
Tower Research Capital (TRC)
New York
$6K +$5.55K +406 New
JMPWA
23
JP Morgan Private Wealth Advisors
California
$5K – – –
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
– -$9K -660 Closed
GI
25
Gradient Investments
Minnesota
– -$27 -2 -67%

VTGN Hedge Fund Activity: Q2 2020 in Review

25 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q2 2020, worth a combined $1.33M — up 29% from $1.02M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new VTGN positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $33.3K. The largest seller was Vanguard Group, cutting an estimated $19K.

  • 25 institutional investors held VistaGen Therapeutics (VTGN) as of Q2 2020, up from 22 in Q1 2020.
  • Funds reported $1.33M of VistaGen Therapeutics stock for Q2 2020, up 29% quarter-over-quarter.
  • 5 funds opened new VistaGen Therapeutics positions in Q2 2020 and 2 closed out, a net change of +3 holders.
  • The largest VistaGen Therapeutics buyer in Q2 2020 was Jane Street, an estimated $33.3K added.
  • The largest VistaGen Therapeutics seller in Q2 2020 was Vanguard Group, an estimated $19K sold.

Based on aggregated 13F filings for Q2 2020.